Eukaryotic Cluster Of Differentiation 2 (CD2)

Eukaryotic expression

Product No.

EPB576Hu61

Organism Species

Homo sapiens (Human).

Source

Eukaryotic expression

Host

293F cell

Endotoxin Level

<1.0EU per 1µg (determined by the LAL method)

Subcellular Location

Membrane

Predicted Molecular Mass

22.8kDa

Accurate Molecular Mass

33-40kDa(Analysis of differences refer to the manual)

Residues & Tags

Lys25~Asp209 with N-terminal His Tag

Buffer Formulation

20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.

Traits

Freeze-dried powder

Purity

> 95%

Isoelectric Point

8.9

Applications

Positive Control; Immunogen; SDS-PAGE; WB.

If bio-activity of the protein is needed, please check active protein.

UOM

5X10^5

SEQUENCE

 

 

 

USAGE

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

 

Catalog No.	Related products for research use of Homo sapiens (Human) Organism species	Applications (RESEARCH USE ONLY!)
EPB576Hu61	Eukaryotic Cluster Of Differentiation 2 (CD2)	Positive Control; Immunogen; SDS-PAGE; WB.
RPB576Hu01	Recombinant Cluster Of Differentiation 2 (CD2)	Positive Control; Immunogen; SDS-PAGE; WB.
APB576Hu61	Active Cluster Of Differentiation 2 (CD2)	Cell culture; Activity Assays.
RAB576Hu21	Recombinant Antibody to Cluster Of Differentiation 2 (CD2)	WB; IF; ICC; IHC; IP; FCM.
FAB576Hu02	Anti-Cluster Of Differentiation 2 (CD2) Monoclonal Antibody	Flow cytometry.
FAB576Hu04	Anti-Cluster Of Differentiation 2 (CD2) Monoclonal Antibody	FCM
FAB576Hu06	Anti-Cluster Of Differentiation 2 (CD2) Monoclonal Antibody	FCM